Kayee International Group Co Ltd
TWSE:2939
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kayee International Group Co Ltd
TWSE:2939
|
TW |
|
Panacea Life Sciences Holdings Inc
OTC:PLSH
|
US |
|
E
|
Erbud SA
F:9DP
|
PL |
|
A
|
Aecon Group Inc
XMUN:2AE
|
CA |
|
AC Partners Inc
OTC:ACPS
|
US |
|
Sevens Atelier Ltd
SGX:5EW
|
SG |
|
A
|
Ahlers AG
DUS:AAH
|
DE |
|
Meghmani Finechem Ltd
NSE:MFL
|
IN |
|
Cornerstone Capital Resources Inc
XTSX:CGP
|
CA |
|
Q
|
Quinsam Capital Corp
CNSX:QCA
|
CA |
|
E
|
EEMS Italia SpA
F:E2Y
|
IT |
Wall St Price Targets
Price Targets Summary
Kayee International Group Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Kayee International Group Co Ltd's stock price target?
Not Available
Kayee International Group Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Kayee International Group Co Ltd?
Projected CAGR
44%
Over the last 10 years, the compound annual growth rate for Revenue has been -10%. The projected CAGR for the next 8 years is 44%.
What is the Gross Profit forecast for Kayee International Group Co Ltd?
Projected CAGR
66%
Over the last 10 years, the compound annual growth rate for Gross Profit has been -20%. The projected CAGR for the next 8 years is 66%.